Our world today and our world in 2020, requires us to change the way that we work in order to understand the unique value of a therapy well before filing, then to demonstrate this value and communicate it to a broad group of stakeholders.
As we start a new year, we are pleased to share our perspectives on what the next five years will hold for the industry and our plan for targeted investments to help our client achieve optimal access for their compounds. The paper will look at:
1. Environmental overview
2. Leveraging secondary data assets to support real-world research
3. Mobile devices in real-world research
4. The role of social media in real-world research
5. Enabling organizational design: the medical affairs CRO of tomorrow